ABY-029 Head & Neck Trial

NCT07279116 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: ABY-029

Sponsor

Dartmouth-Hitchcock Medical Center

Collaborators

[object Object]
[object Object]